MODULATION OF MURINE HEPATIC LIPASE ACTIVITY BY EXOGENOUS AND ENDOGENOUS KUPFFER-CELL ACTIVATION

被引:7
作者
MAGILAVY, DB [1 ]
ZHAN, RJ [1 ]
BLACK, DD [1 ]
机构
[1] UNIV CHICAGO,LA RABIDA & WYLER CHILDRENS HOSP,DEPT PEDIAT,CHICAGO,IL 60637
关键词
D O I
10.1042/bj2920249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deficiency of hepatic lipase (HL) may play a role in the lipoprotein abnormalities in chronic inflammatory states which are characterized by reticuloendothelial-system activation and cytokine release. HL triacylglycerol hydrolase activity was measured in heparin perfusates of livers from autoimmune MRL/1pr mice, which spontaneously develop a condition closely resembling human lupus erythematosis and exhibit spontaneous Kupffer-cell activation after 8 weeks of age, as well as from normal mice treated with Corynebacterium parvum or polyinosinic-polycytidylic acid complex [poly(I . C)] to induce Kupffer-cell activation. HL activity in MRL/1pr mice older than 8 weeks was 29.5 % (P = 0.002) of that in age-matched control MRL/+ + mice. Treatment of normal mice with C. parvum or poly(I.C) resulted in HL activities 18.6 % (P = 0.004) and 13.1 % (P = 0.007) respectively of untreated controls. Northern-blot hybridization of liver poly(A)+ RNA showed no differences in HL mRNA abundance in MRL/+ + mice compared with the MRL/1pr autoimmune strain after 8 weeks of age, or in normal control mice compared with those treated with C. parvum, indicating attenuation of HL activity at the translational or post-translational level. Deficiency of this enzyme may represent one of the mechanisms contributing to the dyslipoproteinaemia of autoimmune disease and chronic infection.
引用
收藏
页码:249 / 252
页数:4
相关论文
共 32 条
[11]  
HASHIMOTO S, 1985, CANCER IMMUNOL IMMUN, V20, P117
[12]   DYSLIPOPROTEINEMIA IN PEDIATRIC SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ILOWITE, NT ;
SAMUEL, P ;
GINZLER, E ;
JACOBSON, MS .
ARTHRITIS AND RHEUMATISM, 1988, 31 (07) :859-863
[13]   METABOLIC FUNCTION OF HEPARIN-RELEASABLE LIVER LIPASE [J].
JANSEN, H ;
VANTOL, A ;
HULSMANN, WC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 92 (01) :53-59
[14]   AUTOIMMUNE HYPERCHYLOMICRONEMIA [J].
KIHARA, S ;
MATSUZAWA, Y ;
KUBO, M ;
NOZAKI, S ;
FUNAHASHI, T ;
YAMASHITA, S ;
SHO, N ;
TARUI, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (19) :1255-1259
[15]  
KNAUER TE, 1982, J LIPID RES, V23, P621
[16]   HEPATIC RETICULOENDOTHELIAL SYSTEM ACTIVATION IN AUTOIMMUNE MICE - DIFFERENCES BETWEEN (NZB X NZW)F1 AND MRL-LPR LPR STRAINS [J].
MAGILAVY, DB ;
HUNDLEY, TR ;
STEINBERG, AD ;
KATONA, IM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 42 (03) :386-398
[17]   SPONTANEOUS PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA BY KUPFFER CELLS OF MRL/LPR MICE [J].
MAGILAVY, DB ;
ROTHSTEIN, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02) :789-794
[18]  
MASUNO H, 1984, J LIPID RES, V25, P419
[19]   MYOCARDIAL-INFARCTION DUE TO CORONARY ATHEROSCLEROSIS IN 3 YOUNG-ADULTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
MELLER, J ;
CONDE, CA ;
DEPPISCH, LM ;
DONOSO, E ;
DACK, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1975, 35 (02) :309-314
[20]   TUMOR NECROSIS FACTOR/CACHECTIN INTERACTS WITH ENDOTHELIAL-CELL RECEPTORS TO INDUCE RELEASE OF INTERLEUKIN-1 [J].
NAWROTH, PP ;
BANK, I ;
HANDLEY, D ;
CASSIMERIS, J ;
CHESS, L ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1363-1375